Social Media Ideas for Crnx

Biggest stock movers Tuesday: CRNX, RIVN, and more

Conexeu Sciences: Hanging On The FDA 510(k) Pathway Submission

NRx Pharmaceuticals, Inc. (NRXP) Q1 2026 Earnings Call Transcript

Why This Pharmaceutical Stock Jumped Close to 100% This Week

It is getting acquired by a larger firm in the sector.

Conexeu Sciences Reports Manufacturing Scale Up and Regulatory Progress for Lead CXUâ„¢ Wound Care Program

Activities are intended to support regulatory testing and the Company’s planned first-quarter 2027 FDA 510(k) premarket notification submission

Hedge Fund Drops $37 Million on Rare Disease Biotech Crinetics. Is It a Buy?

Crinetics Pharmaceuticals develops oral therapies for rare endocrine diseases.

Hedge Fund Drops $37 Million on Rare Disease Biotech Crinetics. Is It a Buy?

Crinetics Pharmaceuticals develops oral therapies for rare endocrine diseases.

Nurix Therapeutics, Inc. (NRIX) Discusses Strategic Collaboration for Development and Commercialization of Bexobrutideg...

Corvus Pharmaceuticals, Inc. (CRVS) Presents at Jefferies Global Healthcare Conference 2026 - Slideshow

Ceragon (CRNT) Q1 2026 Earnings Transcript

Image source: The Motley Fool. DATETuesday, May 19, 2026 at 8:30 a.m. ETCALL PARTICIPANTSChief Executive Officer — Doron AraziChief Financial Officer — Ronen SteinTAKEAWAYSRevenue...

Ceragon (CRNT) Q1 2026 Earnings Transcript

Image source: The Motley Fool. DATETuesday, May 19, 2026 at 8:30 a.m. ETCALL PARTICIPANTSChief Executive Officer — Doron AraziChief Financial Officer — Ronen SteinTAKEAWAYSRevenue...

Circle Internet Group, Inc. (CRCL) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript

Nexxen International Ltd. (NEXN) Analyst/Investor Day Transcript

Canadian National Railway Company (CNR:CA) Presents at Wolfe Research 19th Annual Global Transportation & Industrial...

Credo: The AI Connectivity Winner Emerges

Crane NXT: Priced For Perfection While Antares Masks A Decaying Core

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Discusses Clinical Data Update From Phase 1/2 Study of CRB-701 Presented at...

Vertex Eyes Expansion Beyond Cystic Fibrosis with Planned $10B Crinetics Buyout

Based in San Diego, Crinetics focuses on discovering, developing, and commercializing therapeutics for endocrine diseases. The company’s first marketed drug Palsonify® (paltusotine...

Corxel gears up for global pivotal push after oral GLP-1 posts ‘competitive’ ph. 2 results

With a balance of competitive efficacy and tolerability, Corxel figures it has a potential winner to take into late-stage development.

NexPoint Residential Trust, Inc. (NXRT) Presents at Nareit REITweek: 2026 Investor Conference - Slideshow

Cardiff Oncology, Inc. (CRDF) Discusses Updated Phase II CRDF-004 Data on Onvansertib in First-Line RAS-Mutated Metastat...

Kiniksa Pharmaceuticals: Leader In Pericarditis Merits Hold Rating After Recent Gains

Canadian National Railway Company (CNR:CA) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript

Onward Medical N.V. (ONWRY) Q1 2026 Earnings Call Transcript